Abstract
Background
Primary axillary hyperhidrosis (PAH) is an embarassing, socially disabling condition, most commonly seen in young people. Previous treatments for this condition have included sympathectomy or axillary skin excision. Recently botulinum toxin has been used to provide effective, non-invasive treatment for this condition.
Aims
To investigate the effect of botulinum toxin injection in patients with PAH on sweat production and psychological wellbeing.
Methods
Ten patients were assessed before treatment with botulinum toxin injection using gravimetric analysis and a psychometric questionnaire. Patients were reassessed at intervals of one, four and twelve weeks following treatment.
Results
Injection with botulinum toxin resulted in significant improvement in patients physical symptoms and psychological wellbeing. However, improvement was short-lived with recurrence of symptoms at three months.
Conclusion
Botulinum toxin injection provides very effective short-term relief of PAH. While its limitations should be recognised and explained when consenting patients for treatment this does not necessarily diminish its value in the treatment of PAH.
Similar content being viewed by others
References
Heckman M, Ceballos-Baumann AO, Plewig G. Botulinim toxin A for axillary hyperhidrosis (excessive sweating).N Engl J Med 2001: 7: 488–93.
Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.Br Med J 2001;323: 596–9.
Schnider P, Binder M, Kittler H et al. A randomised, double-blind, placebo-controlled trial of botulinum A toxin for severe axillary hyperhidrosis.Br J Dermatol 1999;140: 677–680.
Naumann M, Lowe NJ, on behalf of the Hyperhidrosis Clinical Study Group. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.Br Med J 2001;323: 1
Ojimba TA, Cameron AEP. Drawbacks of endoscopic thoracic sympathectomy.Br J Surg 2004;91: 264–269.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hanlon, L., Cahill, R. & Barry, M.C. Prospective evaluation of the efficacy of dermal botulinium toxin for primary axillary hyperhidrosis. Ir J Med Sci 175, 57–58 (2006). https://doi.org/10.1007/BF03169003
Issue Date:
DOI: https://doi.org/10.1007/BF03169003